[1]
Sweety Kumari et al. 2025. Revisiting fosfomycin to treat urinary tract infections in the era of rising carbapenem resistance. Asian Journal of Medical Sciences. 16, 4 (Apr. 2025), 119–125. DOI:https://doi.org/10.71152/ajms.v16i4.4471.